Brief: Akari Therapeutics Announces New Data Supporting Use Of Drug Candidate Votucalis
09/03/2022 12:32
March 9 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS ANNOUNCES NEW DATA SUPPORTING USE OF DRUG CANDIDATE
VOTUCALIS
TARGETING DIFFICULT TO TREAT PAIN AND ITCH
* AKARI THERAPEUTICS - LOCAL ADMINISTRATION OF VOTUCALIS ACHIEVED AT
SIGNIFICANTLY
LOWER DOSES, PRODUCED LONGER DURATION OF EFFECT THAN SYSTEMIC ADMINISTRATION
Source text for Eikon: ID:nGNX94BR16
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))